CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Glavni autor: | Ullah, Mohammad |
---|---|
Daljnji autori: | Islam, Farzana |
Format: | Disertacija |
Jezik: | English |
Izdano: |
Brac University
2023
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/19355 |
Similar Items
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
od: Maria, Amatul
Izdano: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
od: Shaikat, Mahdi Mubin
Izdano: (2023) -
A review on CRISPR-Cas system based applications in Oncology
od: Sadia, Mir
Izdano: (2022) -
A review on CRISPR Technology as an Antiviral Tool
od: Srishti, Sanjida Ahmed
Izdano: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
od: Eva, Israt Ara Jannat
Izdano: (2023)